FDA
approval
· 2022-03-11
FDA Approved: AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
Summary
FDA approved a supplemental application to authorize Aurobindo Pharma Limited's generic fixed-dose combination tablet containing amlodipine, valsartan, and hydr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE (AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE)